We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIEQ icon
2901
Amplify AI Powered Equity ETF
AIEQ
$125M
$510K ﹤0.01%
16,877
-458
-3% -$15.4K
GLO
2902
Clough Global Opportunities Fund
GLO
$258M
$510K ﹤0.01%
69,429
-3,979
-5% -$32.3K
AE
2903
DELISTED
Adams Resources & Energy Inc
AE
$510K ﹤0.01%
15,848
-369
-2% -$13.3K
FCEL icon
2904
FuelCell Energy
FCEL
$1.63B
$509K ﹤0.01%
4,523
+228
+5% +$28.7K
ATRA icon
2905
Atara Biotherapeutics
ATRA
$83.1M
$508K ﹤0.01%
+2,609
New +$426K
NCZ
2906
Virtus Convertible & Income Fund II
NCZ
$306M
$507K ﹤0.01%
40,118
-1,437
-3% -$20.7K
LTPZ icon
2907
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$745M
$506K ﹤0.01%
7,764
-24,474
-76% -$1.78M
RFDA icon
2908
ALPS Dynamic US Dividend Advantage ETF
RFDA
$90.6M
$506K ﹤0.01%
11,745
-19,421
-62% -$893K
PCEF icon
2909
Invesco CEF Income Composite ETF
PCEF
$823M
$505K ﹤0.01%
26,700
+3,130
+13% +$63.3K
DMLP icon
2910
Dorchester Minerals
DMLP
$1.35B
$503K ﹤0.01%
21,080
-2,833
-12% -$77.8K
RPRX icon
2911
Royalty Pharma
RPRX
$26.4B
$502K ﹤0.01%
+11,948
New +$490K
ARWR icon
2912
Arrowhead Research
ARWR
$12.3B
$501K ﹤0.01%
14,225
-7
-0% -$263
LTC
2913
LTC Properties
LTC
$2.1B
$501K ﹤0.01%
13,048
-6,104
-32% -$225K
INKM icon
2914
State Street Income Allocation ETF
INKM
$75.6M
$500K ﹤0.01%
16,271
-2,146
-12% -$69.5K
BTG icon
2915
B2Gold
BTG
$6.7B
$499K ﹤0.01%
147,133
-36,748
-20% -$153K
ONON icon
2916
On Holding
ONON
$10.6B
$499K ﹤0.01%
28,190
-930
-3% -$20.1K
DIN icon
2917
Dine Brands
DIN
$462M
$498K ﹤0.01%
7,656
+203
+3% +$14.5K
GLP icon
2918
Global Partners
GLP
$1.72B
$498K ﹤0.01%
21,192
+5,635
+36% +$150K
AZEK
2919
DELISTED
The AZEK Co
AZEK
$497K ﹤0.01%
29,696
-74,046
-71% -$1.52M
CRBN icon
2920
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.19B
$497K ﹤0.01%
3,636
+69
+2% +$10.3K
LHCG
2921
DELISTED
LHC Group LLC
LHCG
$497K ﹤0.01%
3,191
-22,972
-88% -$3.78M
HIO
2922
Western Asset High Income Opportunity Fund
HIO
$340M
$496K ﹤0.01%
125,369
-10,913
-8% -$45.5K
EXC icon
2923
CALL
Exelon
EXC
$46.6B
$495K ﹤0.01%
22,400
-13,800
-38% -$649K
NG icon
2924
NovaGold Resources
NG
$3.45B
$495K ﹤0.01%
102,970
+15,069
+17% +$94.2K
NOMD icon
2925
Nomad Foods
NOMD
$1.59B
$495K ﹤0.01%
24,762
+6,625
+37% +$134K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.